Risperdal M-tab Tablet, Orally Disintegrating
Product Images NDC 50458-355

32 FDA label images from Janssen Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 32 technical images submitted to the FDA as part of the official labeling for Risperdal M-tab (NDC 50458-355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Risperdal 01)

Chemical Structure (Risperdal 01)
Chemical structure of the active ingredient risperidone, as presented in the image.*
FDA Label Image

Figure (Risperdal 02)

Figure (Risperdal 02)
An illustration showing two medical items labeled as Bottle and Syringe. The bottle has a cap and a label with numbers. The syringe is labeled with its parts: Tip, Barrel, and Plunger. The drawing is a simple line art representation.*
FDA Label Image

Step 1 (Risperdal 03)

Step 1 (Risperdal 03)
An instructional illustration showing the first step to open a child-resistant bottle cap. It depicts a hand pressing down on the cap while simultaneously turning it counterclockwise, demonstrating the push-and-turn mechanism commonly used for safety caps on medication bottles.*
FDA Label Image

Step 2 (Risperdal 04)

Step 2 (Risperdal 04)
An instructional illustration showing two hands using a syringe or pen injector device. One hand holds the device while the other presses a button or plunger, indicated by a black arrow pointing downward. This likely demonstrates a step in preparing or administering an injection.*
FDA Label Image

Step 3 (Risperdal 05)

Step 3 (Risperdal 05)
Illustration showing hands using a syringe to withdraw medication from a bottle, with an arrow indicating downward pressure on the syringe plunger. This instructional image depicts a step in medication preparation, likely for oral liquid administration.*
FDA Label Image

Step 4 (Risperdal 05a)

Step 4 (Risperdal 05a)
An instructional illustration showing a hand lifting a syringe plunger upward from a vial, with a close-up inset pointing to measurement markings on the syringe barrel, indicating correct dosage measurement.*
FDA Label Image

Step 5 (Risperdal 05b)

Step 5 (Risperdal 05b)
An instructional illustration showing a hand holding a vial and another hand pulling a syringe upward to withdraw liquid from the vial. The image is step 5 in a sequence, demonstrating the proper technique for drawing medication into a syringe from a vial.*
FDA Label Image

Figure 6a (Risperdal 05c)

Figure 6a (Risperdal 05c)
An instructional diagram showing a hand holding a dropper or syringe and dispensing liquid into a clear glass containing water. This image likely illustrates a step in preparing an oral liquid medication for administration, relevant to risperidone oral formulations.*
FDA Label Image

Figure 6b (Risperdal 05d)

Figure 6b (Risperdal 05d)
An instructional illustration showing the administration of an oral medication with a syringe. The image depicts a person's mouth open with a syringe inserted, accompanied by an arrow indicating the direction of medication delivery into the mouth.*
FDA Label Image

Step 7 (Risperdal 05e)

Step 7 (Risperdal 05e)
Illustration showing hands opening a medication bottle by twisting the cap counterclockwise. The image visually instructs the opening of a child-resistant container, typically used for oral tablets like RISPERDAL (risperidone).*
FDA Label Image

Step 8 (Risperdal 05f)

Step 8 (Risperdal 05f)
An instructional illustration showing two hands holding syringes, with one syringe being aligned or connected to the other. Dotted lines suggest a step or process in drug preparation or administration.*
FDA Label Image

Figura (Risperdal 05g)

Figura (Risperdal 05g)
An instructional diagram showing two medical items labeled in Spanish: a bottle (Frasco) on the left and a syringe (Jeringa) on the right. The syringe is further labeled to identify the tip (Punta), cylinder (Cilindro), and plunger (Émbolo).*
FDA Label Image

Paso 1 (Risperdal 05h)

Paso 1 (Risperdal 05h)
An instructional illustration showing hands opening a child-resistant bottle cap by pressing down and turning the cap simultaneously. The image demonstrates the proper technique for opening a safety-sealed medication bottle.*
FDA Label Image

Paso 2 (Risperdal 05i)

Paso 2 (Risperdal 05i)
Illustration showing step 2 of an injection procedure, depicting hands holding a syringe with an arrow indicating downward pressure on the plunger to administer the medication.*
FDA Label Image

Paso 3 (Risperdal 05j)

Paso 3 (Risperdal 05j)
An instructional illustration showing a hand inserting a syringe into a vial with a downward arrow indicating the direction of insertion, suggesting how to draw medication from the vial.*
FDA Label Image

Paso 4 (Risperdal 05k)

Paso 4 (Risperdal 05k)
An instructional illustration showing a hand pulling a syringe upwards from a vial, with a close-up circle highlighting the measurement markings on the syringe barrel for accurate dosing.*
FDA Label Image

Paso 5 (Risperdal 05l)

Paso 5 (Risperdal 05l)
An instructional illustration showing a hand using a syringe to withdraw liquid medication from a vial. The vial is held steady by one hand while the other hand pulls the syringe plunger upward to draw the medication out.*
FDA Label Image

Figura 6a (Risperdal 05m)

Figura 6a (Risperdal 05m)
An instructional illustration showing a hand holding a syringe or dropper, used to dispense liquid into a glass of water. The image indicates the action of releasing drops into the liquid, likely demonstrating how to prepare an oral liquid medication for administration.*
FDA Label Image

Figura 6b (Risperdal 05n)

Figura 6b (Risperdal 05n)
An instructional illustration showing a person placing the tip of an oral dosing device into their mouth. The diagram includes an arrow indicating the direction for inserting the device for oral administration.*
FDA Label Image

Paso 7 (Risperdal 05o)

Paso 7 (Risperdal 05o)
An instructional illustration showing two hands opening a medication bottle. One hand holds the bottle steady, while the other hand grips the cap, turning it counterclockwise to remove it. This depicts how to open a child-resistant bottle cap, typically used for prescription drugs like RISPERDAL tablets.*
FDA Label Image

Paso 8 (Risperdal 05p)

Paso 8 (Risperdal 05p)
An instructional diagram showing hands holding a syringe and a smaller graduated cylinder or syringe. Dotted lines flow downward, suggesting transfer or measurement of liquid. The background includes a partial view of a human torso, indicating administration or measurement near the body.*
FDA Label Image

Principal Display Panel (0.5 mg Bottle Label)

Principal Display Panel (0.5 mg Bottle Label)
Label for RISPERDAL (risperidone) tablets, 0.5 mg strength. The oral tablet packaging contains 60 tablets. The label includes storage instructions, manufacturer information for Janssen Pharmaceuticals, Inc., and NDC 50458-302-06. The label advises keeping the product out of reach of children and refers to accompanying product literature for dosage.*
FDA Label Image

Principal Display Panel (1 mg Bottle Label)

Principal Display Panel (1 mg Bottle Label)
Risperdal 0.25 mg tablets label displaying the brand name and generic name risperidone. The label indicates each tablet contains 0.25 mg of risperidone, with a package quantity of 60 tablets. Manufacturer information includes Janssen Pharmaceuticals, Inc. and Janssen Ortho LLC. Storage instructions and dosage directions are noted along with a barcode and NDC number 50458-301-04.*
FDA Label Image

Principal Display Panel (2 mg Bottle Label)

Principal Display Panel (2 mg Bottle Label)
Label for RISPERDAL tablets containing risperidone 0.5 mg. The label shows the dosage strength, tablet count of 60, and instructions to keep out of reach of children. Manufactured by Janssen Pharmaceuticals, Inc., it includes storage information and barcode with NDC 50458-302-06.*
FDA Label Image

Principal Display Panel (3 mg Bottle Label)

Principal Display Panel (3 mg Bottle Label)
RISPERDAL 1 mg tablets label displaying the product name with the generic name risperidone. The label indicates each tablet contains 1 mg of risperidone and the package contains 60 tablets. Manufacturer is Janssen Pharmaceuticals, Inc. Storage instructions and caution to keep out of reach of children are included. NDC 50458-300-06 is shown along with dosing information directing to see accompanying literature.*
FDA Label Image

Principal Display Panel (4 mg Bottle Label)

Principal Display Panel (4 mg Bottle Label)
Label for RISPERDAL (risperidone) tablets, 2 mg strength. The label indicates each tablet contains 2 mg risperidone with a package size of 60 tablets. It includes storage instructions, manufacturer details as Janssen Pharmaceuticals, Inc., and a barcode with NDC 50458-320-06.*
FDA Label Image

Principal Display Panel (0.5 mg Tablet Carton)

Principal Display Panel (0.5 mg Tablet Carton)
RISPERDAL 3 mg tablets packaging label showing the brand name RISPERDAL and generic name risperidone. The label indicates the strength as 3 mg per tablet with a quantity of 60 tablets. It states that each tablet contains risperidone 3 mg and includes usage and storage instructions by Janssen Pharmaceuticals, Inc. The label also shows the NDC number 50458-330-06.*
FDA Label Image

Principal Display Panel (1 mg Tablet Carton)

Principal Display Panel (1 mg Tablet Carton)
RISPERDAL tablets 4 mg oral dosage form label. Each tablet contains 4 mg risperidone. The label indicates a package of 60 tablets, labeled for prescription use only by Janssen Pharmaceuticals, Inc. Storage instructions and manufacturer information are included. NDC 50458-350-06 is visible.*
FDA Label Image

Principal Display Panel (2 mg Tablet Carton)

Principal Display Panel (2 mg Tablet Carton)
Risperdal M-TAB 0.5 mg oral disintegrating tablets carton showing 28 tablets per pack. The label includes the NDC 50458-395-28 and indicates each tablet contains 0.5 mg risperidone. The package is labeled Rx only and manufactured by Janssen Pharmaceuticals, Inc. Additional details include storage instructions and a barcode on the back panel.*
FDA Label Image

Principal Display Panel (3 mg Tablet Carton)

Principal Display Panel (3 mg Tablet Carton)
Risperdal M-Tab 1 mg orally disintegrating tablets carton for 28 tablets by Janssen Pharmaceuticals, Inc. The blister pack contains 7 cards of 4 tablets each. The label states each tablet contains 1 mg of risperidone and includes storage and safety information. NDC 50458-315-28.*
FDA Label Image

Principal Display Panel (4 mg Tablet Carton)

Principal Display Panel (4 mg Tablet Carton)
Packaging label for Risperdal M-TAB risperidone orally disintegrating tablets in 1 mg and 2 mg strengths. The label indicates 28 tablets per blister pack, with 7 cards of 4 tablets each. Manufactured by Janssen Pharmaceuticals, Inc., the package includes storage and handling details along with a barcode and NDC 50458-315-28 for 1 mg and 50458-325-28 for 2 mg tablets.*
FDA Label Image

Risperdal Os 1mg (Risperdal Os 1mg Carton)

Risperdal Os 1mg (Risperdal Os 1mg Carton)
Packaging label for RISPERDAL (risperidone) oral solution, 1 mg/mL, manufactured by Janssen Pharmaceuticals, Inc. The label includes dosage information, storage instructions, and a 30 mL Rx only package size. It features the Johnson & Johnson logo and notes the product is made in Ireland.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.